Current fellow
We are excited to announce that Sarah Al-Jilaihawi has been awarded the 2nd ALADDIN Fellowship. This prestigious grant will span six months, from September 2024 to February 2025.
During this period, Sarah will deliver a comprehensive report that will pave the way for further development of the PRO’s research work plan. This report will also serve as a foundation for publication in peer-reviewed journals, focusing on PRO’s in pediatric oncology.
We look forward to the impactful contributions Sarah will make to the field through this fellowship.
About the Fellowship
12-month full time research fellowship within the ACCELERATE organisation including completion of a research project in regulatory science for childhood cancer drug development, participation in the ALADDIN educational course and involvement in wider ACCELERATE activities. Participants will be able to take a flexible working approach whilst completing the fellowship, with a combination of virtual and in-person working at the ACCELERATE office in Brussels available. The fellowship will be fully funded by the ALADDIN project under the EU Erasmus Programme.
The fellowship will be open to applications from the following groups: Paediatric oncologist or pharmacist in late stages of training with special focus on drug development
-
- For physicians: Have finished a medical residency/specialty (paediatrics, medical oncology, clinical pharmacy, or other relevant specialties) and have completed at least 18 months of training in paediatric oncology.
- For pharmacists: Be a graduated PharmD and have completed at least 2 years of post-graduate training/experience (specialisation in Clinical Pharmacology, Oncology, Regulatory Affairs or other relevant areas are a plus)
One candidate will be recruited per year. Applications for 2023 are now closed.
Who can apply?
